Metropolitan Life Insurance CO Pa Vmed Inc. Transaction History

Metropolitan Life Insurance CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$2.46 - $8.74 $34,321 - $121,940	-13,952 Closed	0 $0
Q3 2021 Jun 21, 2023	BUY	$5.1 - $9.39 $71,155 - $131,009	13,952 New	13,952 $119,000
Q3 2021 Mar 30, 2023	SELL	$5.1 - $9.39 $33,813 - $62,255	-6,630 Reduced 32.21%	13,952 $119,000
Q3 2021 Nov 15, 2021	SELL	$5.1 - $9.39 $33,813 - $62,255	-6,630 Reduced 32.21%	13,952 $119,000
Q2 2021 Jun 21, 2023	BUY	$3.95 - $6.88 $81,298 - $141,604	20,582 New	20,582 $131,000
Q2 2021 Mar 30, 2023	BUY	$3.95 - $6.88 $81,298 - $141,604	20,582 New	20,582 $131,000
Q2 2021 Aug 16, 2021	BUY	$3.95 - $6.88 $81,298 - $141,604	20,582 New	20,582 $132,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $93.7M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.